Improved Overall Survival in Melanoma with Combined Dabrafenib and Trametinib.

Research output: Contribution to journal › Article › peer-review

Original language	English
Pages (from-to)	30-39
Journal	New England Journal Of Medicine
Volume	372
Issue number	1
DOIs	https://doi.org/10.1056/NEJMoa1412690
Publication status	Published - 16 Nov 2014

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

@article{1787f9df6cee46d6b0276797b5754d4e,

title = "Improved Overall Survival in Melanoma with Combined Dabrafenib and Trametinib.",

author = "Paul Lorigan",

year = "2014",

month = nov,

day = "16",

doi = "10.1056/NEJMoa1412690",

language = "English",

volume = "372",

pages = "30--39",

journal = "New England Journal Of Medicine",

issn = "0028-4793",

publisher = "Massachussetts Medical Society",

number = "1",

}